BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835]
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4835.htm
Number Citing Articles
1
Daphne Pinheiro, Isabelle Dias, Thiago Freire, Alessandra Alves Thole, Ana Carolina Stumbo, Erika Afonso Costa Cortez, Lais de Carvalho, Simone Nunes de Carvalho. Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosisLife Sciences 2021; 281: 119768 doi: 10.1016/j.lfs.2021.119768
2
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic ApproachesLivers 2022; 2(4): 372 doi: 10.3390/livers2040028
3
Asrin Ahmadi, Hossein Niknahad, Huifeng Li, Ali Mobasheri, Ram Kumar Manthari, Negar Azarpira, Khadijeh Mousavi, Bahman Khalvati, Yangfei Zhao, Jianyu Sun, Yuqi Zong, Mohammad Mehdi Ommati, Reza Heidari. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicityToxicology Letters 2021; 349: 12 doi: 10.1016/j.toxlet.2021.05.012
4
Kun Li, Jinfa Zheng, Han Liu, Qing Gao, Mengmeng Yang, Jiarong Tang, Hui Wang, Sheng Li, Yingbiao Sun, Xuhong Chang. Whole-transcriptome sequencing revealed differentially expressed mRNAs and non-coding RNAs played crucial roles in NiONPs-induced liver fibrosisEcotoxicology and Environmental Safety 2022; 248: 114308 doi: 10.1016/j.ecoenv.2022.114308
5
Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver DiseasesNutrients 2022; 14(11): 2303 doi: 10.3390/nu14112303
6
Jianping Sheng, Baohang Zhang, Yongfeng Chen, Fuxiang Yu. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophagesImmunopharmacology and Immunotoxicology 2020; 42(6): 556 doi: 10.1080/08923973.2020.1811308
7
Tao Li, GuangYue Su, YuQing Zhao. Anti‐hepatic fibrosis effects of AD‐2 affecting the Raf–MEK signaling pathway and inflammatory factors in thioacetamide‐induced liver injuryJournal of Food Science 2021; 86(6): 2753 doi: 10.1111/1750-3841.15731
8
Jianxia Wen, Dan Wang, Jian Wang, Ruilin Wang, Shizhang Wei, Yanling Zhao, Chih-Yuan Ko. Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5574010
9
Sujie Liu, Juan Wu, Pingping Chen, Shadi A. D. Mohammed, Jingbo Zhang, Shumin Liu, Syed Sameer Aga. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut AxisBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4949148
10
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
11
Chang Fan, Fu Rong Wu, Jia Fu Zhang, Hui Jiang. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver FibrosisEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/4780383
12
Luiza M. Karzakova, Antonina L. Ivanova, Sergei I. Kudryashov, Evgeniya V. Sokolova, Tatyana S. Lutkova. IMMUNE MECHANISMS FOR THE DEVELOPMENT OF HEPATORENAL SYNDROME IN LIVER CIRRHOSISActa medica Eurasica 2020; (3): 7 doi: 10.47026/2413-4864-2020-3-7-19
13
Baharan Fekry, Aleix Ribas‐Latre, Rachel Van Drunen, Rafael Bravo Santos, Samay Shivshankar, Yulin Dai, Zhongming Zhao, Seung‐hee Yoo, Zheng Chen, Kai Sun, Frances M. Sladek, Mamoun Younes, Kristin Eckel‐Mahan. Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesisThe FASEB Journal 2022; 36(9) doi: 10.1096/fj.202101398R
14
Simona-Rebeca Ignat, Sorina Dinescu, Anca Hermenean, Marieta Costache. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis DevelopmentCells 2020; 9(2): 461 doi: 10.3390/cells9020461
15
Ya Yang, Yalei Zhao, Lingjian Zhang, Fen Zhang, Lanjuan Li. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety IssuesFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.655268
16
Nazli Khodayari, Regina Oshins, L. Shannon Holliday, Virginia Clark, Qiang Xiao, George Marek, Borna Mehrad, Mark Brantly. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargoCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00648-0
17
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen. Cellular Mechanisms of Liver FibrosisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.671640
18
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo, Zhengquan Su. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathwaysPharmacology & Therapeutics 2021; 222: 107752 doi: 10.1016/j.pharmthera.2020.107752
19
Haili Wang, Jinying Che, Kai Cui, Wenyue Zhuang, He Li, Jinghui Sun, Jianguang Chen, Chunmei Wang. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivoPhytomedicine 2021; 88: 153609 doi: 10.1016/j.phymed.2021.153609
20
Mustafa Ghanim, Johnny Amer, Ahmad Salhab, Nidal Jaradat. Ecballium elaterium improved stimulatory effects of tissue-resident NK cells and ameliorated liver fibrosis in a thioacetamide mice modelBiomedicine & Pharmacotherapy 2022; 150: 112942 doi: 10.1016/j.biopha.2022.112942
21
Sergio C. Oliveira, M. Victoria Delpino, Guillermo Hernán Giambartolomei, Jorge Quarleri, Gary Splitter. Editorial: Advances in Liver Inflammation and Fibrosis Due to Infectious DiseasesFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01760
22
Yu-long Bao, Li Wang, Hai-ting Pan, Tai-ran Zhang, Ya-hong Chen, Shan-jing Xu, Xin-li Mao, Shao-wei Li. Animal and Organoid Models of Liver FibrosisFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.666138
23
Yimin Sun, Bingyan Liu, Jianping Xie, Xuefeng Jiang, Baolai Xiao, Xiaomiao Hu, Jinjian Xiang. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signalingMolecular Medicine Reports 2022; 25(5) doi: 10.3892/mmr.2022.12697
24
Mishghan Zehra, James C. Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic FibrosisInternational Journal of Molecular Sciences 2020; 21(13): 4737 doi: 10.3390/ijms21134737
25
Zuleyha Erisgin, Hasan Serdar Mutlu, Yavuz Tekelioglu, Engin Deveci, Ugur Seker. Hepatotoxic effects of melamine exposure from the weaning period in rats: a flow cytometric, electron microscopic, and histopathologic studyToxicology Research 2021; 10(3): 418 doi: 10.1093/toxres/tfab022
26
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori RadixBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5462063
27
Xingtao Zhao, Jing Wang, Ying Deng, Li Liao, Mengting Zhou, Cheng Peng, Yunxia Li. Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanismPhytotherapy Research 2021; 35(9): 4727 doi: 10.1002/ptr.7104
28
Rui Qin, Qian Zhao, Bo Han, Hong-Ping Zhu, Cheng Peng, Gu Zhan, Wei Huang. Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of FibrosisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.845892
29
Hui Yang, Juan Wang, Zhen‐Guo Liu. Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosisJournal of Cellular and Molecular Medicine 2022; 26(10): 2757 doi: 10.1111/jcmm.17277
30
Ibrahim A Ahmed, Miran A Jaffa, Mayssam Moussa, Duaa Hatem, Ghewa A El-Achkar, Rola Al Sayegh, Mia Karam, Eva Hamade, Aida Habib, Ayad A Jaffa. Plasma Kallikrein as a Modulator of Liver Injury/RemodelingFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.715111
31
Pablo Muriel. Hepatic Fibrosis2022; : 55 doi: 10.1016/B978-0-323-99764-5.00014-7
32
Erika Ramos-Tovar, Pablo Muriel. Vitamins and Hormones 2022;  doi: 10.1016/bs.vh.2022.09.006